alexa Regenerative Medicine Impact Factor|OMICS International|Translational Medicine

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Regenerative Medicine Impact Factor

Impact Factor is a population statistic that reflects how many citations of a journal’s papers published over a two-year period receive during the subsequent year. “The annual Journal Citation Reports impact factor is a ratio between citations and recent citable items published: a journal’s impact factor is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years. Medical Journals provide a podium for unresolved research around the globe in the field of medicine. Medical journals contribute for the advancement and development of the scientific discoveries. Medical journals publish papers which provide information on diagnosis, treatment & prevention of various diseases. OMICS group medical journals papers publishing over 13000 articles every year, accessible to more than 100000 scholars throughout the world. With the support of more than 1000+ Scientific associations OMICS is a leading scientific event organizer, organizing 3000+ International Scientific Conferences all over the globe. The emerging Human Pluripotent Stem Cell (hPSC) technology brings many excitements for regenerative medicine and drug discovery.While the use of hPSC-derived cells for regenerative medicine has more hurdles compared to drug discovery due to the tumorigenecity and immunogenecity, the attractive unlimited cells of human source motivate the exploration of hPSCs for regenerative medicine.The use of oligodendrocyte progenitors in spinal cord injury models and the retinal pigment epithelial cells for treating macular degenerations have been attempted in clinical trials. The formation of 3-Dimentional (3-D) liver bud by co-culturing iPSC-derived hepatic endoderm cells with human mesenchymal stem cells and human umbilical vein endothelial cells regenerated vascularized and metabolically active human liver in vivo.All these studies demonstrated the therapeutic potential of hPSCs in regenerative medicine. (Yan Li and Shang-Tian Yang, Advances in Human Pluripotent Stem Cells for Regenerative Medicine and Drug Discovery)
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on July, 2014